The latest closing stock price for TransCode Therapeutics as of January 21, 2025 is 3.52.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-335 today, roughly 0 times their original investment - a -9.68% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 9.75 on December 04, 2024.
The TransCode Therapeutics 52-week high stock price is 9.89, which is 181% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.22, which is 93.8% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 1.18.
An investor who bought $1,000 worth of TransCode Therapeutics stock at the IPO in 2021 would have $-335 today, roughly 0 times their original investment - a -9.68% compound annual growth rate over 4 years.
The all-time high TransCode Therapeutics stock closing price was 9.75 on December 04, 2024.
The TransCode Therapeutics 52-week high stock price is 9.89, which is 181% above the current share price.
The TransCode Therapeutics 52-week low stock price is 0.22, which is 93.8% below the current share price.
The average TransCode Therapeutics stock price for the last 52 weeks is 1.18.